Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Carolina Bustos Rivera-Bahena"'
Publikováno v:
Universidad Autónoma del Estado de Morelos
UAEM
Repositorio Institucional de Acceso Abierto de la Universidad Autónoma del Estado de Morelos
UAEM
Repositorio Institucional de Acceso Abierto de la Universidad Autónoma del Estado de Morelos
RESUMEN La Artritis Reumatoide es una enfermedad autoinmune e inflamatoria, que incrementa significativamente la morbilidad y qué si no es tratada adecuadamente, posiblemente ocasionará discapacidad y deterioro en la calidad de vida del paciente. A
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3056::0c7a1f5dee6c205e5d8b893251c1135c
http://riaa.uaem.mx/handle/20.500.12055/784
http://riaa.uaem.mx/handle/20.500.12055/784
Autor:
Sandra Carrillo-Vázquez, Carolina Bustos Rivera-Bahena, José Luis Montiel-Hernández, Judith González-Christen, Daniel-Xavier Xibillé-Friedmann
Publikováno v:
Reumatología Clínica (English Edition). 12:323-326
Objective To evaluate the association between the clinical activity of RA patients and serum adipocytokines (Leptin, Adiponectin and Resistin) and inflammatory cytokines. Methods All RA patients fulfilled ACR 1987 criteria and were treated with DMARD
Autor:
José Luis Montiel-Hernández, Janitzia Vázquez-Mellado, Sergio García-Méndez, D. Xibille-Friedmann, Ingris Peláez-Ballestas, Carolina Bustos Rivera-Bahena, Everardo Álvarez-Hernández, Rubén Burgos-Vargas
Publikováno v:
Medicine
The aim of this study was to determine the levels of leptin (Lep) and adiponectin (AdipoQ) in patients with gout and its relationship with joint inflammatory data and/or with metabolic syndrome (MetS) variables, during 1 year follow-up. Forty-one pat
Autor:
Daniel-Xavier, Xibillé-Friedmann, Eduardo, Ortiz-Panozo, Carolina, Bustos Rivera-Bahena, Marisol, Sandoval-Ríos, Sara-Eugenia, Hernández-Góngora, Liliana, Dominguez-Hernandez, José-Luis, Montiel-Hernández
Publikováno v:
Clinical and experimental rheumatology. 33(4)
To assess whether baseline levels of leptin and adiponectin predict disease activity or response to treatment in patients with RA at 6 months, 1 and 2 years of follow-up.A consecutive cohort of patients, classified according to the 2010 ACR/EULAR RA